Danaher Co. (NYSE:DHR) Receives Consensus Recommendation of "Moderate Buy" From Analysts
Danaher Co. (NYSE:DHR) Receives Consensus Recommendation of "Moderate Buy" From Analysts
Danaher Co. (NYSE:DHR – Get Rating) has received a consensus recommendation of "Moderate Buy" from the fourteen research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $310.17.
據市場評級公司報道,Danaher Co.(紐約證券交易所股票代碼:DHR-GET Rating)已經收到了14家研究公司的一致建議,即“適度買入”。兩名股票研究分析師對該股的評級為持有建議,十名分析師給該公司指定了買入建議。在去年更新了對該股覆蓋範圍的分析師中,平均12個月的價格目標是310.17美元。
A number of equities analysts recently commented on the company. StockNews.com downgraded Danaher from a "strong-buy" rating to a "buy" rating in a report on Thursday. Sanford C. Bernstein started coverage on Danaher in a report on Tuesday, August 16th. They set an "outperform" rating and a $340.00 target price for the company. Robert W. Baird decreased their price objective on Danaher from $325.00 to $315.00 and set an "outperform" rating for the company in a report on Friday, October 21st. Royal Bank of Canada reduced their price target on Danaher from $318.00 to $302.00 and set an "outperform" rating for the company in a report on Friday, October 21st. Finally, JPMorgan Chase & Co. reduced their price target on Danaher from $350.00 to $315.00 and set an "overweight" rating for the company in a report on Friday, October 21st.
一些股票分析師最近對該公司發表了評論。StockNews.com在週四的一份報告中將Danaher的評級從“強勢買入”下調至“買入”.桑福德·C·伯恩斯坦在8月16日星期二的一份報告中開始了對丹納赫的報道。他們為該公司設定了“跑贏大盤”的評級和340.00美元的目標價。羅伯特·W·貝爾德將他們對Danaher的目標價從325.00美元下調至315.00美元,並在10月21日星期五的一份報告中為該公司設定了“跑贏大盤”的評級。加拿大皇家銀行將他們對Danaher的目標價從318.00美元下調至302.00美元,並在10月21日(週五)的一份報告中為該公司設定了“跑贏大盤”的評級。最終,摩根大通將丹納赫的目標價從350.00美元下調至315.00美元,並在10月21日星期五的一份報告中對該公司設定了“增持”評級。
Danaher Stock Down 0.9 %
Danaher股價下跌0.9%
Shares of DHR opened at $269.34 on Friday. The firm has a market cap of $196.07 billion, a P/E ratio of 29.76, a P/E/G ratio of 2.12 and a beta of 0.83. The stock has a 50 day simple moving average of $260.68 and a two-hundred day simple moving average of $266.38. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.78 and a quick ratio of 1.38. Danaher has a 1 year low of $233.71 and a 1 year high of $331.23.
上週五,DHR的股價開盤報269.34美元。該公司市值為1960.7億美元,市盈率為29.76倍,市盈率為2.12倍,貝塔係數為0.83。該股的50日簡單移動均線切入位為260.68美元,200日簡單移動均線切入位為266.38美元。該公司的債務權益比為0.41,流動比率為1.78,速動比率為1.38。丹納赫的一年低點為233.71美元,一年高位為331.23美元。
Danaher Dividend Announcement
丹納赫宣佈分紅
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Thursday, December 29th. Danaher's payout ratio is 11.05%.
該公司最近還披露了季度股息,將於1月27日(星期五)支付。12月30日(星期五)登記在冊的股東將獲得0.25美元的股息。這意味着年化股息為1.00美元,收益率為0.37%。除股息日期為12月29日(星期四)。Danaher的派息率為11.05%。
Insiders Place Their Bets
內部人士下注
In other Danaher news, CFO Matthew Mcgrew sold 18,935 shares of Danaher stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $274.72, for a total value of $5,201,823.20. Following the sale, the chief financial officer now owns 29,634 shares of the company's stock, valued at approximately $8,141,052.48. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Matthew Mcgrew sold 18,935 shares of the business's stock in a transaction on Friday, November 11th. The stock was sold at an average price of $274.72, for a total transaction of $5,201,823.20. Following the completion of the transaction, the chief financial officer now owns 29,634 shares in the company, valued at approximately $8,141,052.48. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Joakim Weidemanis sold 9,508 shares of the business's stock in a transaction on Monday, November 28th. The shares were sold at an average price of $266.60, for a total value of $2,534,832.80. Following the transaction, the executive vice president now owns 71,498 shares of the company's stock, valued at approximately $19,061,366.80. The disclosure for this sale can be found here. Insiders have sold a total of 39,038 shares of company stock valued at $10,550,749 in the last quarter. 11.20% of the stock is currently owned by insiders.
在Danaher的其他新聞中,CFO Matthew McGrew在11月11日星期五的一筆交易中出售了18,935股Danaher股票。這隻股票的平均售價為274.72美元,總價值為5201,823.20美元。出售後,首席財務官現在擁有29,634股公司股票,價值約8,141,052.48美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接。在相關新聞中,首席財務官馬修·麥格魯在11月11日星期五的一次交易中出售了18,935股該公司的股票。該股以274.72美元的平均價格出售,總成交金額為5201,823.20美元。交易完成後,首席財務官現在擁有該公司29,634股,價值約8,141,052.48美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接。此外,執行副總裁Joakim Weidemanis在11月28日星期一的一次交易中出售了9508股該公司的股票。這些股票的平均價格為266.60美元,總價值為2,534,832.80美元。交易完成後,執行副總裁總裁現在持有該公司71,498股股票,價值約19,061,366.80美元。關於這次銷售的披露可以找到這裏。上個季度,內部人士總共出售了39,038股公司股票,價值10,550,749美元。該公司11.20%的股份目前由內部人士持有。
Institutional Inflows and Outflows
機構資金流入和流出
Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in Danaher by 1.9% during the 3rd quarter. Vanguard Group Inc. now owns 53,690,131 shares of the conglomerate's stock valued at $13,867,623,000 after purchasing an additional 995,501 shares during the last quarter. Northern Trust Corp boosted its position in Danaher by 0.8% during the second quarter. Northern Trust Corp now owns 8,061,833 shares of the conglomerate's stock worth $2,043,836,000 after purchasing an additional 65,824 shares in the last quarter. Legal & General Group Plc boosted its position in Danaher by 6.4% during the second quarter. Legal & General Group Plc now owns 4,656,373 shares of the conglomerate's stock worth $1,180,485,000 after purchasing an additional 279,432 shares in the last quarter. Amundi boosted its position in Danaher by 10.2% during the second quarter. Amundi now owns 4,649,220 shares of the conglomerate's stock worth $1,157,183,000 after purchasing an additional 431,694 shares in the last quarter. Finally, Parnassus Investments LLC boosted its position in Danaher by 3.0% during the second quarter. Parnassus Investments LLC now owns 4,622,607 shares of the conglomerate's stock worth $1,171,923,000 after purchasing an additional 135,251 shares in the last quarter. 77.27% of the stock is owned by institutional investors and hedge funds.
對衝基金最近增持或減持了該業務的股份。先鋒集團(Vanguard Group Inc.)第三季度增持丹納赫股份1.9%。先鋒集團目前持有53,690,131股該集團股票,價值13,867,623,000美元,上個季度又購買了995,501股。北方信託公司在第二季度將其在Danaher的頭寸增加了0.8%。北方信託公司目前持有該集團8,061,833股股票,價值2,043,836,000美元,此前該公司在上個季度又購買了65,824股。Legal&General Group Plc在第二季度將其在Danaher的頭寸增加了6.4%。Legal&General Group Plc現在擁有該集團4,656,373股股票,價值1,180,485,000美元,上個季度又購買了279,432股。Amundi在第二季度將其在Danaher的頭寸增加了10.2%。Amundi現在持有該集團4,649,220股股票,價值1,157,183,000美元,上個季度又購買了431,694股。最後,Parnassus Investments LLC在第二季度將其在Danaher的頭寸增加了3.0%。Parnassus Investments LLC現在擁有該集團4,622,607股股票,價值1,171,923,000美元,上個季度又購買了135,251股。77.27%的股票由機構投資者和對衝基金持有。
About Danaher
關於丹納赫
(Get Rating)
(獲取評級)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
丹納赫公司在全球設計、製造和營銷專業、醫療、工業和商業產品和服務。該公司通過三個部門運營:生命科學、診斷和環境與應用解決方案。生命科學部門提供質譜儀;流式細胞術、基因組學、實驗室自動化、離心法、顆粒計數和表徵;顯微鏡;基因組耗材;以及基因和細胞治療。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- MarketBeat: Week in Review 12/05 – 12/09
- There Is Fundamental Value In Broadcom, And It Yields 3.35%
- Costco vs Amazon: an end of the year showdown
- Discount Retailers Could Make Good Bargain Stocks
- Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
- 免費獲取StockNews.com關於Danaher的研究報告(DHR)
- MarketBeat:回顧一週12/05-12/09
- 博通有基本面價值,收益率為3.35%
- 好市多VS亞馬遜:年底攤牌
- 折扣零售商可以做好的便宜貨
- 輝瑞、強生能否繼續跑贏該指數?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
接受《丹納赫日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Danaher和相關公司的最新新聞和分析師評級的每日簡要摘要。